Update on the diagnosis and treatment of choroidal hemangioma

Area of Science:

• Ophthalmology
• Oncology
• Vascular Biology

Background:

• Choroidal hemangioma (CH) is a benign vascular tumor originating in the choroid.
• Two subtypes exist: circumscribed (CCH) and diffuse (DCH), the latter often linked to Sturge-Weber syndrome.
• CH may be asymptomatic; symptomatic cases frequently present with decreased visual acuity due to retinal detachment.

Purpose of the Study:

• To review the diagnosis and management of choroidal hemangioma.
• To highlight the shift in treatment paradigms with the advent of photodynamic therapy.
• To emphasize the importance of accurate diagnosis for appropriate patient management.

Main Methods:

• Review of diagnostic imaging modalities for CH detection and monitoring.
• Analysis of treatment outcomes, focusing on photodynamic therapy (PDT).
• Discussion of differential diagnosis to prevent unnecessary interventions.

Main Results:

• Multimodal imaging facilitates accurate CH diagnosis and surveillance.
• Photodynamic therapy has emerged as the primary treatment for symptomatic CH.
• PDT has demonstrably improved the visual prognosis for patients with CH.

Conclusions:

• Accurate diagnosis and differential diagnosis of CH are crucial for appropriate management.
• Photodynamic therapy represents a significant advancement in treating symptomatic choroidal hemangiomas.
• The improved visual prognosis underscores the efficacy of PDT as the treatment of choice for CH.